Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.

Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jing Sun, Guibo Sun, Xiangbao Meng, Hongwei Wang, Yun Luo, Meng Qin, Bo Ma, Min Wang, Dayong Cai, Peng Guo, Xiaobo Sun
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science (PLoS) 2013-01-01
Serija:PLoS ONE
Online pristup:http://europepmc.org/articles/PMC3665796?pdf=render
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items